HYBRID EVENT: You can participate in person at Orlando, Florida, USA or Virtually from your home or work.
Precision Medicine in Diabetes Treatment
Precision medicine is growing more popular, and it is defined as an evolving approach to disease treatment and prevention that considers individual heterogeneity in genes, environment, and lifestyle. Big data, genomics, and other “omics” such as metabolomics, proteomics, and transcriptomics could make the promise of personalized medicine a reality in the not-too-distant future. Precision diabetes research is progressing at a breakneck pace. While it is still too early to declare that we have arrived at a point where every diabetic patient can receive a personalized treatment, we are beginning to recognize that one size does not fit all.
- Precision diabetes
- Genetic diabetes
Committee Members
Bob Esquerre
Esquerre Fitness Group International, United States
F Buck Willis
IUHS School of Medicine, Saint Kitts and Nevis
Wan Rosli Wan Ishak
Universiti Sains Malaysia, MalaysiaSubmit your abstract Today
Title : Does winter melon (benincasa hispida) improves nutritional values and ameliorating glycaemic parameters?
Wan Rosli Wan Ishak, Universiti Sains Malaysia, Malaysia
Title : Effect of a community-based health behaviour intervention on health-related quality of life in people with type 2 diabetes in Nepal: a cluster randomized controlled trial
Ashmita Karki, Central Queensland University, Australia
Title : Microalbuminuria and its correlation with HbA1c levels in newly diagnosed type 2 diabetics: a cross-sectional study
Sammon Khan Tareen, University Hospitals Birmingham, United Kingdom
Title : The Menopausal Mind: Reframing female senescence as a neuroendocrine disorder with root cause management strategies
Amy Gutman, AdventHealth; Tough Love MD, United States
Title : Effect of BASNEF- based Nutrition education on nutritional behaviors among elderly people and mini nutritional assessment(MNA) on nutritional status in elderly with diabetes with Type 2 diabetes (A clinical trial intervention)
Davoud Shojaeizadeh, Tehran University of Medical Sciences, Iran (Islamic Republic of)
Title : Association of Autoimmune Pathologies withType1 Diabetes: Epidemiological, clinical and metabolic aspects
Touzani Asmae, chu-Children's hospital, Morocco